Two Sigma Advisers’s T2 Biosystems, Inc TTOO Stock Holding History

Two Sigma Advisers’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44	Closed	-$355K	–	2754
2021 Q1	$355K	Buy	+44	New	+$466K	﹤0.01%	2162
2018 Q4	–	Sell	-7	Closed	-$244K	–	2496
2018 Q3	$244K	Sell	7 -1	-13%	-$32.9K	﹤0.01%	2021
2018 Q2	$321K	Buy	+8	New	+$304K	﹤0.01%	2082

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KFS

Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers's TTOO Position: Q2 2021 in Review

Two Sigma Advisers sold out of T2 Biosystems, Inc (TTOO) in Q2 2021, closing a stake of 44 shares — an estimated $355K sold.

Two Sigma Advisers first reported a position in TTOO in Q2 2018 and held it in 3 quarters. The position peaked at $355K in Q1 2021. 78 funds tracked by Wall St. Rank hold TTOO as of Q2 2021.

Two Sigma Advisers reported no remaining T2 Biosystems, Inc position as of Q2 2021 after selling out during the quarter.
Two Sigma Advisers sold 44 T2 Biosystems, Inc shares in Q2 2021, an estimated $355K.
Two Sigma Advisers first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 3 quarters.
Two Sigma Advisers's T2 Biosystems, Inc position peaked at $355K in Q1 2021.
78 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2021.

Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.